Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

5 hrs ago | BioSpace

Move Over San Francisco: Boston Showing Its Pharmaceutical Potential

August 22, 2014 By Krystle Vermes , BioSpace.com Breaking News Staff Boston is renowned for its top educational institutions and biotechnology firms, but there's change in the air that can no longer be ignored.

Comment?

Related Topix: Startups, BioSpace.com, IGN Entertainment, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

9 hrs ago | Seeking Alpha

Tonix Could Match Pfizer's Biggest Drug's Best Market

Tough Times After Lipitor Pfizer is one of the largest pharmaceutical companies in the world, but it has had a rough few years since its best selling drug Lipitor came off patent in 2011.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lipitor, Atorvastatin (generic), Lyrica, Pregabalin (generic), Health, Pain, Fibromyalgia

13 hrs ago | Seeking Alpha

Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going?

Puma Biotech, a small development stage biopharmaceutical company, recently announced positive results in one of their Phase III trials.

Comment?

Related Topix: Medicine, Cancer, Health, Amgen, Healthcare Law, Law, Breast Cancer, Excaliard Pharmaceuticals, Biotech, Healthcare Industry

Thu Aug 21, 2014

Seeking Alpha

Amgen Has Yet To Reach Its Potential, Despite Strong Gains

With shares of Amgen trading at near 52-week highs, investors are getting nervous about the next couple of quarters.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Johnson and Johnson, GlaxoSmithKline

Customer Interaction Solutions

U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein...

U.S. FDA Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism , and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy Bristol-Myers Squibb Company and Pfizer Inc. today announced the U.S. Food and Drug Administration has approved a Supplemental New Drug Application for Eliquis for the ... (more)

Comment?

Related Topix: Healthcare Law, Food and Drug Administration, Law, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex

Reuters

UPDATE 1-FDA approves use of Eliquis to treat leg, lung clots

Bristol-Myers Squibb Co and Pfizer Inc on Thursday said U.S. regulators have approved an expanded use for their Eliquis blood clot preventer, to treat blood clots in the legs and lungs.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Food and Drug Administration, Medicine, Healthcare Industry

Christian Science Monitor

One downside of coprorate inversions: higher tax bills for shareholders

The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Tax, 401K, Personal Finance

Sys-Con Media

Asterias Biotherapeutics Appoints Two Independent Directors and...

With these additions, the Asterias Board of Directors now comprises eight directors, three of whom are independent.

Comment?

Related Topix: Marketing, Biotech, Healthcare Industry, Startups, Geron, Stem Cell Research, Science / Technology, Biotime

Pharmaceutical Processing

Pfizer Initiates Expanded Access Program For Advanced Breast Cancer Treatment

Pfizer Inc. announced that the company has initiated a multi-center, open-label expanded access program in the United States for the investigational CDK 4/6 inhibitor, palbociclib.

Comment?

Related Topix: Biotech, Healthcare Industry, Cancer, Health, Breast Cancer, Healthcare Law, Law, Food and Drug Administration

Jerusalem Post

European stocks edge higher, E.Z. PMIs in focus; Dax up 0.16%

Investing.com - European stocks edged higher on Thursday, after the release of positive German manufacturing and service sector data, while investors still awaited reports for the entire euro zone.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, AstraZeneca Group, Healthcare Industry

Wed Aug 20, 2014

The Washington Post

AstraZeneca Is Tougher Pfizer Target as Possible New Bid Looms

Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Parsippany, NJ, Business News

Freshnews

American Lung Association Urges Adults with Lung Disease to Consult...

Children aren't the only segment of our population who can receive vaccinations to help prevent disease.

Comment?

Related Topix: Charitable Organizations, American Lung Association, Vaccinations, Health, Centers for Disease Control and Prevention, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals

BioSpace

Bristol-Myers Squibb Company And Pfizer Inc. To Present New Data On...

Bristol-Myers Squibb Company and Pfizer Inc. announced today that they will present 14 abstracts at the ESC Congress 2014, organized by the European Society of Cardiology, to be held August 30 to September 4 in Barcelona, Spain.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pfizer, Foldrx Pharmaceuticals

BioSpace

Pfizer Inc.s Mergers And Budget Cuts Hurt Cancer R&D

At Pfizer PFE +0.35%'s second quarter 2014 earnings call, Ms. Jami Rubin, an industry analyst for Goldman Sachs, posed Pfizer CEO, Ian Read, the following question.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Superfish is the #1 ranked software... )--CTRL was formed to create a forum where an open source philosophy is used to incorporate the best ideas in the practice of law through a range of technological innov... )--The AcroMetrix Oncology Hotspot Control provides a quality control material that can be used in laboratories with different NGS ... (more)

Comment?

Related Topix: Semiconductors, Vishay Intertechnology, Electronics, Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Energy, AES, Retail, Target

Tue Aug 19, 2014

Business Journal

Hawaii-based Cardax partners with Capsugel to market astaxanthin

Hawaii-based pharmaceutical company Cardax is partnering with major drug capsule manufacturer Capsugel to mass-produce the anti-inflammatory nutritional supplement called astaxanthin.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

The Motley Fool

3 Reasons Pfizer Inc.'s Stock Could Rise

Yet, if you've been a shareholder in Pfizer over the past 15 years, and didn't purchase Pfizer stock during the Great Recession, things haven't been so great from a share price perspective.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Healthcare Law, Law

Customer Interaction Solutions

Manhattan Scientifics Reaches the Fork (Falk) in the Road

Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics .

Comment?

Related Topix: Marketing, Forest Laboratories, Pfizer, Biotech, Medicine, Forest Labs, Healthcare Industry, Oncology

Reuters

UPDATE 1-U.S. clears AstraZeneca over heart drug trial

The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects.

Comment?

Related Topix: Marketing, US News, Biotech, Medicine, Healthcare Industry

Mon Aug 18, 2014

GuruFocus.com

Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

According to GuruFocus list of 52-week lows , these Guru stocks have reached their 52-week lows.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Vodafone Group, Telecom

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••